Phase IIa Study of the Immunogenicity and Safety of the Novel Staphylococcus aureus Vaccine V710 in Adults with End-Stage Renal Disease Receiving Hemodialysis

Bacteremia is the second leading cause of death in patients with end-stage renal disease who are on hemodialysis. A vaccine eliciting long-term immune responses against Staphylococcus aureus in patients on chronic hemodialysis may reduce the incidence of bacteremia and its complications in these pat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Moustafa, Moustafa, Aronoff, George R., Chandran, Chandra, Hartzel, Jonathan S., Smugar, Steven S., Galphin, Claude M., Mailloux, Lionel U., Brown, Elizabeth, DiNubile, Mark J., Kartsonis, Nicholas A., Guris, Dalya
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2012
Assuntos:
Vaccines
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3428394/
https://ncbi.nlm.nih.gov/pubmed/22837094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00034-12
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados